Aquestive Therapeutics, Inc.AQ.STNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank29
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P29
Within normal range
vs 5Y Ago
-1.1x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -23.06% |
| 2024 | 22.14% |
| 2023 | 371.15% |
| 2022 | -12.61% |
| 2021 | -60.90% |
| 2020 | 21.95% |
| 2019 | 231.47% |
| 2018 | 2.29% |
| 2017 | -49.28% |
| 2016 | 75.31% |